| 000 | 01551nam a2200289Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625153916.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-13120 | ||
| 245 | 1 | 0 | _aPorous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2 |
| 490 | 0 | _vJournal of Controlled Release, 134(2), p.111-117, 2009 | |
| 520 | 3 | _aIt is advantageous to incorporate controlled growth factor delivery into tissue engineering strategies. The purpose of the present study was to develop a novel tissue engineering scaffold with the capability of controlled releasing BMP-2-derived synthetic peptide. Porous nano-hydroxyapatite/collagen/poly(L-lactic acid)/chitosan microspheres (nHAC/PLLA/CMs)composite scaffolds containing different quantities of chitosan microspheres (CMs)were prepared by a thermally induced phase separation method. Dioxane was used as the solvent for PLLA. Introduction of less than 30 | |
| 650 | 1 | 4 | _aPOLY(L-LACTIC ACID) |
| 650 | 1 | 4 | _aCHITOSAN |
| 650 | 1 | 4 | _aNANO-HYDROXYAPATITE/COLLAGEN (NHAC) |
| 650 | 1 | 4 | _aSYNTHETIC PEPTIDE |
| 650 | 1 | 4 | _aTISSUE ENGINEERING |
| 650 | 1 | 4 | _aCONTROLLED DELIVERY |
| 700 | 1 | 2 | _aNiu, X. |
| 700 | 1 | 2 | _aFeng, Q. |
| 700 | 1 | 2 | _aWang, M. |
| 700 | 1 | 2 | _aGuo, X. |
| 700 | 1 | 2 | _aZheng, Q. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/13PJQsOVeT9UeiVD4Osg1bH8u949DTZTR/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c47322 _d47322 |
||